Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20881 AL 20895

Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders

Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB.

Cell Mol Neurobiol. 2022 Oct;42(7):2075-2095. doi: 10.1007/s10571-021-01093-4. Epub 2021 May 1.

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease

Balmik AA, Chinnathambi S.

Cell Commun Signal. 2021 May 7;19(1):51. doi: 10.1186/s12964-021-00732-z.

How well do people living with neurodegenerative diseases manage their finances? A meta-analysis and systematic review on the capacity to make financial decisions in people living with neurodegenerative diseases

Bangma DF, Tucha O, Tucha L, De Deyn PP, Koerts J.

Neurosci Biobehav Rev. 2021 Aug;127:709-739. doi: 10.1016/j.neubiorev.2021.05.021. Epub 2021 May 28.

When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease

D'Mello SR.

Int J Mol Sci. 2021 May 31;22(11):5911. doi: 10.3390/ijms22115911.

Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective

Su LD, Wang N, Han J, Shen Y.

Neuroscientist. 2022 Oct;28(5):453-468. doi: 10.1177/10738584211021018. Epub 2021 Jun 4.

Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases

Trudler D, Ghatak S, Lipton SA.

Int J Mol Sci. 2021 Jul 30;22(15):8196. doi: 10.3390/ijms22158196.

Early onset Alzheimer's disease - a case study

Łabuz-Roszak B, Torbus-Paluszczak M, Becelewski J, Becelewski M, Dobrakowski P, Pierzchała K.

Psychiatr Pol. 2021 Apr 30;55(2):323-330. doi: 10.12740/PP/OnlineFirst/114122. Epub 2021 Apr 30.

Ophthalmic manifestations of dementing disorders

Douglas VP, Douglas KAA, Cestari DM.

Curr Opin Ophthalmol. 2021 Nov 1;32(6):515-520. doi: 10.1097/ICU.0000000000000807.

Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review

Sampedro F, Kulisevsky J.

J Neuroimaging. 2022 Jan;32(1):28-35. doi: 10.1111/jon.12930. Epub 2021 Sep 10.

Apoptosis and its therapeutic implications in neurodegenerative diseases

Erekat NS.

Clin Anat. 2022 Jan;35(1):65-78. doi: 10.1002/ca.23792. Epub 2021 Oct 7.

Multifaced role of protein deacetylase sirtuins in neurodegenerative disease

Gupta R, Ambasta RK, Kumar P.

Neurosci Biobehav Rev. 2022 Jan;132:976-997. doi: 10.1016/j.neubiorev.2021.10.047. Epub 2021 Nov 3.

Single-cell Transcriptional Changes in Neurodegenerative Diseases

Ahmadi A, Gispert JD, Navarro A, Vilor-Tejedor N, Sadeghi I.

Neuroscience. 2021 Dec 15;479:192-205. doi: 10.1016/j.neuroscience.2021.10.025. Epub 2021 Nov 6.

Retinal imaging biomarkers of neurodegenerative diseases

Christinaki E, Kulenovic H, Hadoux X, Baldassini N, Van Eijgen J, De Groef L, Stalmans I, van Wijngaarden P.

Clin Exp Optom. 2022 Mar;105(2):194-204. doi: 10.1080/08164622.2021.1984179. Epub 2021 Nov 9.

Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease

Adeyemi OS, Awakan OJ, Afolabi LB, Rotimi DE, Oluwayemi E, Otuechere CA, Ibraheem O, Elebiyo TC, Alejolowo O, Arowolo AT.

Oxid Med Cell Longev. 2021 Nov 10;2021:5522981. doi: 10.1155/2021/5522981. eCollection 2021.

Interweaving of reactive oxygen species and major neurological and psychiatric disorders

Umare MD, Wankhede NL, Bajaj KK, Trivedi RV, Taksande BG, Umekar MJ, Mahore JG, Kale MB.

Ann Pharm Fr. 2022 Jul;80(4):409-425. doi: 10.1016/j.pharma.2021.11.004. Epub 2021 Dec 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias